StockData
Colgate Palmolive Co logo

Colgate Palmolive Co (CL) company profile

CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3026% above fair value
$99.67+1.77 (+1.81%)

Close on Nov 13, 2026Market cap $79.23BP/E 39.1Yield 2.09%

About Colgate Palmolive

Perfumes, Cosmetics & Other Toilet Preparations, SIC 2844

Colgate-Palmolive Company produces and sells oral, personal, home care, and pet nutrition products worldwide. Its oral care offerings feature toothpastes, toothbrushes, mouthwashes, and specialized dental pharmaceuticals. Within personal care, the enterprise manufactures liquid and bar soaps, shower gels, deodorants, antiperspirants, skin health items, and hair care formulations. Home care operations include dishwashing liquids, fabric conditioners, and household surface cleaners. Additionally, its pet nutrition business manufactures everyday and therapeutic foods for canines and felines, including fresh dietary selections. The company supplies wholesale distributors, brick-and-mortar retailers, pet specialty outlets, veterinarians, and eCommerce platforms, alongside direct-to-consumer sales.

The enterprise distributes products across more than 200 countries and territories, marketing its pet nutrition items in over 80 jurisdictions. Its workforce comprises roughly 33,600 employees stationed across more than 100 nations, with major regional personnel presence in the Asia Pacific, Latin America, North America, Europe, and Africa/Eurasia. The company maintains an operating presence that includes manufacturing facilities internationally. The provided text identifies the company's incorporation under Delaware state laws, though it does not state a headquarters city or address.

Summary of the business section of Colgate Palmolive's latest annual report, written by StockData.

Company profile

Company

Legal name
Colgate Palmolive Co
Founded
1806
Headquarters
New York, NY
Address
300 Park Ave 10022
Phone
(212) 310-2000
Employees
33,600, Dec 31, 2025
Industry
Perfumes, Cosmetics & Other Toilet Preparations
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, New York, New York

Stock & identifiers

Ticker
CL
Exchange
NYSE
IPO date
May 2, 1973
Shares outstanding
795M, Sep 30, 2026
Public float
$73.40B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, May 16, 2013; 2-for-1, Jul 1, 1999; 2-for-1, May 16, 1997; 2-for-1, May 16, 1991; 3-for-1, May 30, 1973
SEC CIK
21665
CUSIP
194162103
ISIN
US1941621039
FIGI
BBG000BFQYY3
Share class FIGI
BBG001S5PVM5
LEI
YMEGZFW4SBUSS5BQXF88
EIN
13-1815595

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Noel R. WallaceChairman, President & CEO, Director467,208
Gregory MalcolmEVP and Controller18,761
Panagiotis TsourapasCOO, CD, EMEA, APac, Skin80,993
John HazlinChief Growth Officer32,565
Betsy FishboneCLO and Secretary24,436
Sally MasseyChief People Officer23,596
Shane GrantCOO, Americas79,503
Stanley J. Sutula IiiChief Financial Officer79,360
Jennifer DanielsCLO and Secretary91,681
Prabha ParameswaranVice Chair63,783
Lorrie M. NorringtonDirector43,383
Brian NewmanDirector8,094
John P. BilbreyDirector45,444
John T. CahillDirector64,730
Lisa EdwardsDirector18,182
Martina HundmejeanDirector16,206
C. Martin HarrisDirector24,517
Kimberly A. NelsonDirector14,223
Christopher S. BoernerDirector1,383
Steven A. CahillaneDirector6,754

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$16.48M$12.34M$6.36M$104$112
FY2024$18.23M$31.68M$4.88M$117$113
FY2023$17.12M$19.46M$4.71M$100$108
FY2022$14.46M$11.05M$4.06M$97$113
FY2021$15.46M$18.01M$4.09M$102$114
FY2020$14.36M$22.77M$4.02M$127$111

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOption awardsIncentive payOtherTotalvs. prior year
Noel Wallace
Chairman, President and Chief Executive Officer
$1.50M–$8.01M$3.57M$2.46M$947.08K$16.48M-10%
Stanley J. Sutula III
Chief Financial Officer
$1.10M–$2.07M$1.05M$1.19M$252.41K$5.66M-5%
Jennifer M. Daniels
Chief Legal Officer and Secretary
$952.71K–$1.30M$579.01K$718.39K$222.36K$3.77M-13%
Shane Grant
Chief Operating Officer, Americas (7)
$592.31K$500.00K$8.41M$450.01K$1.18M$788.35K$11.92M–
Panagiotis Tsourapas
Chief Operating Officer, Eur., APac, Afr/Eur, Skin and Global Cust. Dev.
$1.00M–$1.31M$600.00K$871.76K$293.64K$4.08M-9%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 33,600 employees based in over 100 countries.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?